The role of hemodialysis machines dedication in reducing Hepatitis C transmission in the dialysis setting in Iran: A multicenter prospective interventional study

BMC Nephrology

Volumn 5, Issue , 2004, Pages 1-5

  Shamshirsaz, Alireza Abdollah ^a,d   Kamgar, Mohammad ^a,d   Bekheirnia, Mir Reza ^a,d   Ayazi, Farzam ^a   Hashemi, Seyed Reza ^a   Bouzari, Navid ^a   Habibzadeh, Mohammad Reza ^a,d   Pourzahedgilani, Nima ^d   Broumand, Varshasb ^a   Shamshirsaz, Amir Hooshang Abdollah ^a   Moradi, Maziyar ^a   Borghei, Mehrdad ^a   Haghighi, Niloofar Nobakht ^c   Broumand, Behrooz ^a,b  

^a IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Pars General Hospital Tehran   (Iran)

^c Iranian Academy of Medical Sciences   (Iran)

^d Science and Technology Dept   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIALYSIS; DISEASE TRANSMISSION; FEMALE; FOLLOW UP; HEMODIALYSIS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INCIDENCE; IRAN; MAJOR CLINICAL STUDY; MALE; MEDICAL INSTRUMENTATION; POLYMERASE CHAIN REACTION; PREVALENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; VIRUS INFECTION; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CROSS INFECTION; INFECTION CONTROL; INSTRUMENTATION; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RENAL REPLACEMENT THERAPY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CROSS INFECTION; DISEASE TRANSMISSION, INFECTIOUS; FEMALE; FOLLOW-UP STUDIES; HEPATITIS C; HUMANS; IRAN; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL DIALYSIS; UNIVERSAL PRECAUTIONS;

EID: 9144245801     PISSN: 14712369     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-5-13     Document Type: Article

References (36)

1. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV related chronic disease. Centers for disease control and prevention. MMWR Recomm Rep 1998, 47:1-39.
2. Alter MJ, Coleman PJ, Alexander WJ, Kramer E, Miller JK, Mandel E, Hadler SC, Margolis HS: Importance of heterosexual activity in the transmission of hepatitis B and non-A non-B hepatitis. JAMA 1989, 262:1201-1205.
3. Ruiz-Moreno M, Leal-Orozco A, Millan A: Hepatitis C virus infection in children. J hepatol 1999, 31:S124-S129.
4. Rosen HR: Acquisition of hepatitis C by a conjunctival splash. Am J Infect Control 1997, 25:242-247.
5. Sartori M, La Terra G, Aglietta M, Manzin A, Navino C, Verzetti G: Transmission of hepatitis C via blood splash into conjunctiva. Scand J Infect Dis 1993, 25:270-271.
6. Knoll A, Helmig M, Peters O, Jilg W: Hepatitis C virus in a pediatric oncology ward: analysis an outbreak and review of the literature. Laboratory investigation 2001, 81(3):251-262.
7. Bronowicki JP, Venard V, Botte C, Monhoven N, Gastin I, Choné L, Hudziak H, Rhin B, Delanoë C, LeFaou A, Bigard MA, Gaucher P: Patient to patient transmission of hepatitis C virus during colonoscopy. N Engl J Med 1997, 337:237-240.
8. Alter MJ: Epidemiolgy of hepatitis C in the West. Semin Liver Dis 1995, 15:5-14.
9. Halfon P, Khiri H, Feryn JM, Sayada C, Chanas M, Ouzan D: Prospective virologic follow-up of hepatitis C infection in a dialysis center. J Viral Hepatitis 1998, 5:115-121.
10. Ouzan D, Halfon P, Chanas M, Khiri H, Feryn JM, Salvadori JM: Relevance of hepatitis C virus RNA detection, qualification, and genotypes in hemodialysis patients. Eur J Int Med 1997, 8:89-93.
11. Khohler H: The prevalence of hepatitis C in different countries of the ERA/EDTA area. Nephrol Dial Transplant 1995,10:468-469.
12. Sanchez-Tapias JM: Nosocomial transmission of hepatitis C virus. J Hepat 1999, 31:S107-S112.
13. Broumand B, Abdollah Shamshirsaz A, Kamgar M, Hashemi R, Aiazi F, Bekheirnia MR, Boozari B, Komeilian Z, Abdollah Shamshirsaz AH, Tabatabaiee MR, Broumand V: Prevalence of hepatitis C infection and its risk factors in hemodialysis patients in Tehran. The Saudi Arabian Journal of Dialysis and Transplantation 2002,13(4):467-472.
14. Nobakht Haghighi A, Zali M R, Nowroozi A: Hepatitis C antibody and related risk factors in hemodialysis patients in Iran. J Am Soc Nephrology 2001, 12:233A.
15. Rais-Jalali G, Hakjehdehi P: Anti-HCV seropositivity among hemodialysis patients of Iranian origin. Nephrol Dial Transplant 1999, 14:2055-56.
16. Allander T, Medin C, Jacobson SH, Grillner L, Perssonn MAA: Hepatitis C transmission in a haemodialysis unit: Molecular evidence for spread of virus among patients not sharing equipment. J Med Virol 1994, 43:415-419.
17. Katsoulidou A, Paraskevis D, Kalapothaki V, Arvanitis D, Karayiannis P, Hadjiconstantiou V, Hatzakis A: Molecular epidemiology of a hepatitis C virus outbreak in a haemodialysis unit. Multicentre Haemodialysis Cohort Study on Viral Hepatitis. Nephrol Dial Transplant 1999, 14:1188-1194.
18. Di Lallo D, Miceli M, Petrosillo N, Perucci CA, Moscatelli M: Risk factors of hepatitis C virus infection in patient on haemodialysis: A multivariate analysis based on a dialysis register in Central Italy. Eur J Epidemiol 1999, 15:11-14.
19. Simon N, Courouce M, Lemarrec N, Trepo C, Ducamp S: A twelveyear natural history of hepatitis C virus infection in haemodialyzed patients. Kidney Int 1994, 46:504-511.
20. Okuda K, Hayashi H, Kobayashi S, Irie Y: Mode of hepatitis C infection not associated with blood transfusion among chronic haemodialysis patients. J Hepatol 1995, 23:28-31.
21. Gilli P, Moretti M, Soffritti S, Marchi N, Malacarne F, Bedani PL, De Paoli Vitali E, Fiocchi O, Menini C: Non-A, non-B hepatitis and anti-HCV antibodies in dialysis patients. Int J Artif Organs 1990,13:737-741.
22. Zali Mohammad Reza, Raoufi Mohammad, Nowroozi Azita: The prevalence of hepatitis C in normal population of 19-45 years old in Iran. 10th international symposium on viral hepatitis and liver disease, Center of Disease Control, Atlanta, Georgia. USA . April 10-13, 2000
23. Simon N, Courouce AM, Lemarrec N, Trepo C, Ducamp S: A twelve year natural history of hepatitis C virus infection in hemodialyzed patients. Kidney Int 1994, 46:504-511.
24. McLaughlin K, Cameron S, Good T, McCruden E, Ferguson J, Davidson F, Simmonds P, Mactier R, McMillan M: Nosocomial transmission of hepatitis C virus within a British dialysis center. Nephrol Dial Transplant 1997, 12:304-309.
25. Le Pogam S, Le Chapois D, Christen R, Dubois F, Barin F, Goudeau A: Hepatitis C in a hemodialysis unit: Molecular evidence for nosocomial transmission. J Clin Microbiol 1998, 36:3040-3043.
26. Alfurayh O, Sabeel A, AlAhdal MN, Almeshari K, Kessie G, Hamid M, Dela Cruz DM: Hand contamination with hepatitis C virus in staff looking after hepatitis C positive hemodialysis patients. Am J Nephrol 2000, 20:103-106.
27. Harmankaya O, Cetin B, Obek A, Seber E: Low prevalence of hepatitis C virus infection in hemodialysis units: effect of isolation. Ren Fail 2002, 24(5):639-44.
28. Taskapan H, Oymak O, Dogukan A, Utas C: Patient to patient transmission of hepatitis C virus in hemodialysis units. Clin Nephrol 2001, 55(6):477-81.
29. Abdelnour GE, Matar GM, Sharara HM, Abdelnoor AM: Detection of anti-hepatitis C virus antibodies and hepatitis C virus RNA in Lebanese hemodialysis patients. Eur J Epidemiol 1997,13(8):863-7.
30. Dos Santos JP, Loureiro A, Cendoroglo Neto M, Pereira BJ: Impact of dialysis room and reuse strategies on the incidence of hepatitis C virus infection in haemodialysis units. Nephrol Dial Transplant 1996, 11(10):2017-22.
31. Seme K, Poljak M, Zuzec-Resek S, Debeljak M, Dovc P, Koren S: Molecular evidence for nosocomial spread of two different hepatitis C virus strains in one hemodialysis unit. Nephron 1997, 77:273-278.
32. Centers for Disease Control: What control measures should be taken when hemodialysis patients are suspected of having non A, non B hepatitis? Atlanta, CDC, No 49: Hepatitis Surveillance Report 1985:3-4.
33. Gilli P, Moretti M, Soffritti S, Menini C: Anti-HCV positive patients in dialysis units. Lancet 1990, 336:243-244.
34. Froio N, Nicastri E, Comandini U, Cherubini C, Felicioni R, Solmone M, Di Giulio S, Petrosillo N: Contamination by Hepatitis B and C Viruses in the Dialysis Setting. American Journal of Kidney Diseases, 2003, 42:546-550.
35. Gilli P, Soffritti S, De Paoli Vitali E, Bedani PL: Prevention of Hepatitis C Virus in Dialysis Units. Nephron 1995, 70:301-306.
36. Cerrai T, Michelassi S, Ierpi C, Toti G, Zignego AL, Lombardi M: Universal precautions and dedicated machines as cheap and effective measures to control HCV spread. EDTNA ERCA J 1998,24(2):43-48.